Singapore: Aveo Oncology and Astellas Pharma announced overall survival (OS) for tivozanib, an investigational agent, fr...
The number of mergers and acquisitions (M&A) that have been made over the past two years have almost returned to pre...
Singapore: BIOTEC, NITE Biological Resource Center (NBRC) and Faculty of Science, Chulalongkorn University signed a p...
Singapore: Japan's Kanagawa Prefecture's Global Collaboration Center for Life Innovation (GCC) and the Agency for Scienc...
Singapore: Takeda and Affymax, announced that Takeda Pharmaceuticals America (TPA) has entered into a supply agreement ...
Singapore: A phase III memorandum of understanding (MoU) was signed between Thailand's BIOTEC and Japan's National Insti...
Singapore: Japanese pharma major Takeda Pharma has announced that it has received approval of Adcetris (brentuximab vedo...
Singapore: Verastem, a biopharmaceutical company focused on discovering and developing drugs to treat breast and other c...
Singapore: Therapeutically focused global clinical research organization, INC Research LLC has announced the establishme...
Singapore: Sosei Group's Japanese subsidiary initiated a phase III trial for SO-1105 for the treatment of oropharyngeal...
Singapore: Researchers from Japan's RIKEN Center for Developmental biology have developed a new sugar and water-based so...
Singapore: US-based Cytokinetics and Japan-based Astellas Pharma entered in a two-year collaboration focused on the R&am...
Singapore: Astellas Pharma and XenoPort have launched Regnite (gabapentin enacarbil) extended-release tablets. Regnite i...
Singapore: The Scripps Research Institute (TSRI) and Takeda Pharmaceutical plan to expand their recent research collabo...
Singapore: Japanese company I'rom Holdings will acquire an 18.8 percent stake in IDT Australia. I'rom is listed on the T...
Singapore: The Japanese unit of AstraZeneca (AZ), has been acquitted, in a case that had held the firm responsible for t...
Asia needs a solution, that goes beyond traditional structure, models and pathways, to meet the essential vaccine supply...
Singapore: Japan's Daiichi Sankyo and Ranbaxy Laboratories have plans to integrate their business operations in Thailand...
Singapore: A new power-free microfluidic chip developed by researchers at the RIKEN Advanced Science Institute, Japan, ...
Singapore: Japan based Hoya Corporation has appointed Mr Augustine Yee as its executive officer, chief legal officer and...
Singapore: Takeda Pharmaceuticals' Deerfield campus has been listed among Chicago's top 100 workplaces by the Chicago T...
Singapore: Japan-based Eisai is going to launch its new carbonated supplement drink named 'Chocola BB Sparkling + Fiber'...
Singapore: Eisai, which has its headquarters in Tokyo, has submitted a marketing authorization application to Japan's Mi...
Singapore: Keryx Biopharmaceuticals announced that its Japanese partner, Japan Tobacco (JT), has filed a New Drug Appli...
Singapore: The US FDA has accepted Astellas Pharma's US subsidiary filing of a supplemental New Drug Application (sNDA) ...
Singapore: The European Medicines Agency (EMA) has accepted the marketing authorization application for review of an aty...
New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and eff...
Singapore: Global biopharmaceutical company Amgen plans to acquire all the outstanding shares of Onyx Pharmaceuticals fo...
Singapore: The TRILOGY ACS study, a phase III trial comparing prasugrel plus aspirin to clopidogrel plus aspirin in pati...
Singapore: Takeda Pharmaceutical mutually terminated its worldwide agreement with Amylin Pharmaceuticals, which was ori...
Singapore: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a posi...
Singapore: Astellas Pharma, Japan's pharmaceutical giant with net sales of $10.7 billion and net income of $881 million ...
Singapore: Sucampo Pharmaceuticals' subsidiary SPL has received a $15 million milestone payment from Abbott's subsidiar...
Singapore: Eisai announched that Scotland's health technology assessment (HTA) body, the Scottish Medicines Consortium ...
Singapore: ZOLL Medical, a manufacturer of medical devices and related software solutions and a wholly owned US subsidi...
Singapore: The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Neupro (rotigotine transdermal patch...
Singapore: AVEO Oncology and Astellas Pharma announced that the US Food and Drug Administration (FDA) has accepted fo...
Singapore: Mundipharma has entered a license agreement with Japan-based Shionogi for the exclusive rights to develop, ma...
Singapore: Cytori Therapeutics announced that a 40-patient, multi-center investigator-sponsored and funded clinical stu...
Singapore: Isogenica has appointed CTC Laboratory Systems (CTCLS) of Tokyo, Japan, to represent its business in Japan. C...
Singapore: ThermoGenesis, a leading supplier of enabling technologies for the processing, storage and administration of ...
Singapore: US based Sanford-Burnham Medical Research Institute and Japan's Daiichi Sankyo have formed a three year disco...
Singapore: Japan-based Takeda Global Research & Development Centre has received confirmation of the acceptance of su...
Singapore: Thailand hospital is planning to introduce Japanese cancer therapy technology using a heavy ion beam to treat...
Singapore: Swiss giant Novartis Pharma's Japanese arm has prompted the Japanese health ministry to launch an investigati...
Singapore: Genmab has entered into a research collaboration with Japan-based Kyowa Hakko Kirin to create bispecific anti...
Singapore: Japan Science and Technology Agency (JST) and the National Science and Technology Development Agency (NSTDA) ...
Singapore: Daiichi Sankyo has submitted an application for a partial label change in Japan to manufacture and market the...
Singapore: Mitsubishi Tanabe Pharma and Daiichi Sankyo will launch selective DPP-4 inhibitor Tenelia 20mg tablets (tenel...
7th in-Pharma Japan and 26th Interphex Japan, which was held from July 10-12, 2013, at Tokyo Big Sight, Japan...
Singapore: Pressures felt in Japan as a result of the country's aging population, drug price revisions and patent expiri...
Singapore: Takeda Pharmaceutical received an Order for Corrective Action regarding the manufacturing and marketing of Al...
Singapore: Thermo Fisher Scientific signed a long-term license agreement with Fujirebio to make its biomarker assay Pro...
Singapore: Japan's Ministry of Health, Labor and Welfare (MHLW) has approved Bayer HealthCare and Onyx Pharmaceuticals's...
Singapore: Japan-based Astellas Pharma and US-headquartered Ambit Biosciences are ending their collaboration for joint d...
Singapore: US-based Edison Pharmaceuticals has entered into a strategic alliance valued up to $4.295 billion with Japan'...
Singapore: US-based Gilead Sciences has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Dev...
Singapore: AnGes MG entered into a definitive agreement with Mitsubishi Tanabe Pharma for the exclusive marketing right...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: A research team at the tissue regeneration materials unit, National Institute for Materials Science (NIMS), s...
Singapore: Japan-based Astellas Pharma has received US FDA approval for Astagraf XL (tacrolimus extended-release capsule...
Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry ser...
Singapore: Pfizer and Mylan have signed a definitive agreement to establish an exclusive long-term strategic collaborati...
Singapore: Japanese firm Takara Bio has entered into an agreement with Invivoscribe Technologies to grant the latter lic...
Singapore: NuVasive, a medical device company focused on developing minimally disruptive surgical products and procedur...
Singapore: Medicago, a biopharmaceutical company focused on developing highly effective and competitive vaccines based o...
Singapore: US-based Kinetic Concepts (KCI) has launched ActiVAC Therapy System for in-patient use in Japan, which is a l...
Singapore: Terumo and Biosensors International announced an extension of their existing licensing agreements, under w...
Singapore: Japanese firm Otsuka Pharmaceutical and global firm H Lundbeck have submitted a New Drug Application (NDA) to...
Singapore: Vital Connect recently announced that its wearable device HealthPatch MD has received approval for sale in th...
Singapore: USA-based Amgen, the world's largest independent biotech company, has expanded its strategic collaboration wi...
Singapore: Taiho Pharmaceutical submitted an application for approval of the manufacture and marketing of the novel oral...
Singapore: Eisai announced that its U.S. subsidiary has received approval from the U.S. Food and Drug Administration (F...
Singapore: Japan-based Arte and German company ProJect Pharmaceutics are working closely on the development of a new typ...
Singapore: Takeda Pharmaceutical Company and LigoCyte Pharmaceuticals, jointly announced that Takeda's wholly-owned sub...
Singapore: The 17th edition of BioJapan is all set to kick off from October 14, 2015 Pacifico Yokohama. Top industry pla...
Singapore: Takeda Pharmaceutical has entered into a partnership with Resolve Therapeutics to develop compounds for the t...
Singapore: LEO Pharma plans to establish five long-term, strategic research collaborations in four countries by the end ...
Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the ...
Singapore: The International Court of Arbitration, International Chamber of Commerce, has issued its arbitral award in t...
Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 m...
Singapore: Japan's Patent Office has granted a key patent to drug and diagnostic company Agenix covering the manufacturi...
Singapore: Astellas Pharma signed a license agreement with Janssen Biotech under which Janssen has an exclusive right to...
Singapore: Scil Proteins, a private biotech company specializing in the research, development and production of recombin...
Singapore: Takeda Pharmaceutical Company acquired URL Pharma through its wholly-owned subsidiary Takeda America Holdings...
Singapore: Eisai announced that the US Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory C...
The playing field for research and development for genetic diagnostics has been leveled. The landmark decision by the US...
The world's largest biotechnology company Amgen entered into a long-term collaboration with Astellas Pharma in May this ...
